Navigating discrepancies: The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment

Navigating discrepancies: The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment

The assessment of residual lymphovascular invasion (LVI) in breast cancer patients undergoing neoadjuvant therapy may be a critical factor influencing prognosis and treatment decisions. However, there is a notable discrepancy between the RCB, UICC/AJCC, and ICCR guidelines regarding how LVI should b...

Full description

Saved in:
Bibliographic Details
Main Authors: Anikó Kovács, Åsa Rundgren-Sellei, Gunilla Rask, Annette Bauer, Anna Bodén, Johannes van Brakel, Eugenia Colón-Cervantes, Anna Ehinger, Johan Hartman, Balazs Acs
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Breast
Subjects:
Neoadjuvant therapy
Pathological complete response
Residual breast carcinoma
Lymphovascular invasion
Residual lymphovascular invasion
Pure intralymphatic breast carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625005363
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

http://www.sciencedirect.com/science/article/pii/S0960977625005363

Similar Items